Physician

David Earl Perry, DO

According to 2025 Medicare claims, David Perry, DO (NPI: 1295029528) practices cardiology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84604-3305. Perry is affiliated with the Aledade 201 National MSSP (ACO ID: A5522) and Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under both the MSSP and REACH models.

Perry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,476 traditional Medicare patients, billed 7,035 HCPCS/CPT codes, and received $431,832 in Medicare payments. The top billing code was 78431 (Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan). Part D data shows 3,497 prescription claims across 751 beneficiaries totaling $1,934,688 in drug costs, led by Vyndamax (Tafamidis). DME data shows 54 claims. Open Payments data shows 54 records totaling $1,058. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $16,196 to $431,832. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,544 to $1,934,688. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	91	188	$16,196
2018	899	3,360	$166,159
2019	1,163	4,358	$227,029
2020	1,035	3,520	$222,451
2021	1,002	4,109	$310,298
2022	1,167	5,369	$347,615
2023	1,383	7,866	$430,392
2024	1,476	7,035	$431,832

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	32	$2,544
2016	N/R	N/R	N/R
2017	64	225	$12,046
2018	218	1,637	$106,922
2019	377	2,448	$216,018
2020	427	2,937	$307,256
2021	488	2,836	$487,541
2022	534	2,732	$491,366
2023	664	3,083	$901,483
2024	751	3,497	$1,934,688

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	31	$3,013
2022	N/R	40	$3,763
2023	N/R	84	$6,420
2024	N/R	54	$4,038

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78431	Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan	126	126	$894
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	438	600	$87
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	765	797	$79
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	148	161	$12
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	179	180	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	45	1,350	$1,105,545
Eliquis	Apixaban	293	17,057	$322,315
Camzyos	Mavacamten	19	550	$153,548
Entresto	Sacubitril/Valsartan	109	5,068	$90,606
Repatha Sureclick	Evolocumab	126	4,522	$87,948

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	37	$3,656
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	17	$382

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$1,058	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Earl Perry, DO?

Tedicare shows public-source Medicare data for David Earl Perry, DO (NPI 1295029528), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Earl Perry, DO have ACO affiliation data?

David Earl Perry, DO is shown with ACO affiliation data for Aledade 201 National MSSP (MSSP, ACO ID A5522) and Revere Health Collaborative Network, LLC (REACH, ACO ID D0042).

What billing organization is linked to David Earl Perry, DO?

David Earl Perry, DO is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does David Earl Perry, DO have Open Payments data?

David Earl Perry, DO has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.